Indiana Health Center COVID-19 Survey Summary Report

Latest data from May 6, 2022

Number of Health Center respondents = 17 (63% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 1,738
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 47.58%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 155
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 41.43%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 46.03% 52.90%
White, Hispanic/Latino Patients 15.19% 18.71%
Black/African American, Non-Hispanic/Latino Patients 16.11% 13.55%
Black/African American, Hispanic/Latino Patients 0.35% 0.00%
Asian Patients3 4.32% 0.00%
American Indian/Alaska Native Patients3 0.17% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.17% 0.00%
Patients with More Than One Race3 1.50% 1.29%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 3.97% 3.87%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.67% 1.29%
Unreported/Refused to Report Race and Ethnicity 10.53% 8.39%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 410
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 71.17%
COVID-19 Immunization Series Completed 528
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 61.07%
COVID-19 Immunization Series Additional 803
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 62.47%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 27.56% 35.98% 37.11%
White, Hispanic/Latino Patients 23.41% 13.64% 12.95%
Black/African American, Non-Hispanic/Latino Patients 23.66% 17.61% 27.52%
Black/African American, Hispanic/Latino Patients 0.49% 0.57% 0.37%
Asian Patients3 2.68% 4.36% 1.99%
American Indian/Alaska Native Patients3 0.00% 0.38% 1.00%
Native Hawaiian/Other Pacific Islander Patients3 0.24% 1.89% 0.62%
Patients with More Than One Race3 5.37% 3.41% 4.23%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 12.20% 14.58% 13.08%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.73% 1.70% 0.75%
Unreported/Refused to Report Race and Ethnicity 3.66% 5.87% 0.37%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 35.29%
1 to 24 Hours 29.41%
More Than 24 Hours 29.41%
N/A 5.88%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 5.88%
Staffing to administer the vaccine 29.41%
Vaccine confidence 47.06%
Vaccine storage capacity 5.88%
Vaccine supply 0.00%
Other 11.76%
None 29.41%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 29.41%
Average Percent of Health Center Visits Conducted Virtually 7.06%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 23.53%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 15
Number of School-Based Vaccination Sites 0
Number of Family Vaccination Clinics 28

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 5.88%
Refer patients to another organization that provides monoclonal antibody therapies 52.94%
None 41.18%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 11.76%
Patient awareness/education 5.88%
Staffing capacity 17.65%
Therapy administration/onsite logistics 17.65%
Other 5.88%
None 58.82%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 12
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 7,732

Test Kit Distribution Methods4

Metrics Value
Provided to Existing Health Center Patients 83.33%
Provided to General Public Who Came to the Health Center 50.00%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 16.67%
Provided at Other Community Events 58.33%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 8.33%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 8.33%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 16.67%
Provided to school-age children and/or their families directly or through partnerships with schools 16.67%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 16.67%
Other 8.33%

N95 Mask Distribution

Metrics Value
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program 9
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program 2,623

N95 Mask Distribution Methods5

Metrics Value
Provided to Existing Health Center Patients 77.78%
Provided to General Public Who Came to the Health Center 66.67%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 22.22%
Provided at Other Community Events 44.44%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 0.00%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 11.11%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 22.22%
Provided to school-age children and/or their families directly or through partnerships with schools 33.33%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 0.00%
Other 11.11%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 1
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication 8.33%

Oral Antiviral Medication Distribution by Race and Ethnicity

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 83.33%
White, Hispanic/Latino Patients 0.00%
Black/African American, Non-Hispanic/Latino Patients 0.00%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 0.00%
American Indian/Alaska Native Patients3 8.33%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Unreported/Refused to Report Race and Ethnicity 8.33%

Oral Antiviral Medication Distribution by Population Type

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 0.00%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.

Date Last Reviewed:  May 2022